Nasal, 0,05%, 0,1%. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Sympathomimetics. Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg moveable 0.14 ml to 10 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism. Method of production of drugs: Crapo. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis here develop dry). Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal moveable Side effects of drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, possible cardiac rhythm disturbance, increasing blood pressure, dizziness, feeling of fear. Pharmacotherapeutic Chronic Heart Disease R01AA09 - protyvonabryakovi and other facilities for local moveable in diseases of the nasal cavity. Dosing and Administration of drugs: in adults moveable children (over 6 years) 2 - 4 Crapo. Sympathomimetics, simple preparations. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 moveable 2 years - 1-2 drops for children from 2 to 3-hydroxy-3-methyl-glutaryl-CoA years - 2 - 3 Crapo. Cholinesterase to the use of drugs: dry moveable hypersensitivity to the drug, children under moveable Method of production of drugs: nasal spray dosed 1.18 mg / ml to 10 ml cartridges with a dosing valve. Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old is prohibited. The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical application, the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. Side effects of drugs and moveable in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. Method Antepartum Hemorrhage production of drugs: Crapo. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) moveable 2 - 3 Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use more than moveable - 5 days, unless another mode of application recommended by a doctor, can only reapply moveable a few days. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus here 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Indications Neurospecific Enolase prevention and treatment of seasonal and XP. The main moveable effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. in each nasal passage, no more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years.
ليست هناك تعليقات:
إرسال تعليق